Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study-Reference-Cited by-同舟云学术

Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study

Published:2023-05 Issue:1 Volume:19 Page:63-72
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:

Author:

van der Sangen Niels M.R.,Claessen Bimmer E.P.M.,Küçük I. Tarik,den Hartog Alexander W.,Baan Jan,Beijk Marcel A.M.,Delewi Ronak,van de Hoef Tim P.,Knaapen Paul,Lemkes Jorrit S.,Marques Koen M.,Nap Alexander,Verouden Niels J.W.,Vis M. Marije,de Winter Robbert J.,Kikkert Wouter J.,Appelman Yolande,Henriques Jose P.S.

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

2. Incidence and prognostic impact of post discharge bleeding post acute coronary syndrome within an outpatient setting: a systematic review

3. Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis

4. Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention

5. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aspirin-free P2Y12 inhibitor monotherapy immediately after percutaneous coronary intervention: A systematic review;Heliyon;2024-08

2. P2Y12 Inhibitor Monotherapy After Short-Term Dual Antiplatelet Therapy in Acute Coronary Syndrome;The American Journal of Cardiology;2024-08

3. Optimal management of high bleeding risk patients undergoing percutaneous coronary interventions: Where do we stand?;Journal of Cardiology;2024-08

4. Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials;European Heart Journal;2024-05-16

5. One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes;EuroIntervention;2024-05